<DOC>
	<DOC>NCT01647555</DOC>
	<brief_summary>This study evaluates the skin toxicities in patients with epidermoid cancer, treated by Radiotherapy in association with Cetuximab.</brief_summary>
	<brief_title>Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Age &gt; 18 years Epidermoid head and neck carcinoma locally advanced Indication of Cetuximab and radiotherapy Karnofsky &gt;= 60 Patients participating to another compatible study could be included after consultation with the study director Patients could be beforehand treated for an other ORL cancer The radiotherapy will be delivered for curative aim (minimal dose 66 Gy) other histology Metastatic disease Recurrent patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Cetuximab</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>epidermoid head and neck cancer</keyword>
</DOC>